Blood cancers

DCEP regimen buys time for multiple myeloma patients

The combination of dexamethasone, cyclophosphamide, etoposide, and cisplatin (DCEP) is an effective bridge to autologous stem cell transplant (ASCT) or novel agents in patients with relapsed refractory multiple myeloma. According to a retrospective review of 65 patients receiving the combination at Alfred Health and Monash Medical Centre between 2005 and 2017, the overall response rate ...

Already a member?

Login to keep reading.

© 2021 the limbic